戻る Agenda
Session 5
Session Chair(s)
Seiki Yamazaki
Director, Clinical Informatics & Innovation
Pfizer Japan Inc., Japan
Speaker(s)
Tatsuhiko Sugimoto
Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Reviewer, Office of Safety II